These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 17373898)

  • 1. Tuning inflammation with anti-inflammatory neuropeptides.
    Varela N; Chorny A; Gonzalez-Rey E; Delgado M
    Expert Opin Biol Ther; 2007 Apr; 7(4):461-78. PubMed ID: 17373898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Keeping the balance between immune tolerance and pathogen immunity with endogenous neuropeptides.
    Gonzalez-Rey E
    Neuroimmunomodulation; 2010; 17(3):161-4. PubMed ID: 20134192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory neuropeptides: a new class of endogenous immunoregulatory agents.
    Delgado M; Ganea D
    Brain Behav Immun; 2008 Nov; 22(8):1146-51. PubMed ID: 18598752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Cortistatin in the Stressed Immune System.
    Delgado M; Gonzalez-Rey E
    Front Horm Res; 2017; 48():110-120. PubMed ID: 28245456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous anti-inflammatory neuropeptides and pro-resolving lipid mediators: a new therapeutic approach for immune disorders.
    Anderson P; Delgado M
    J Cell Mol Med; 2008 Oct; 12(5B):1830-47. PubMed ID: 18554314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptides as pleiotropic modulators of the immune response.
    Souza-Moreira L; Campos-Salinas J; Caro M; Gonzalez-Rey E
    Neuroendocrinology; 2011; 94(2):89-100. PubMed ID: 21734355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of cortistatin as a new immunomodulatory factor with therapeutic potential in immune disorders.
    Gonzalez-Rey E; Delgado M
    Mol Cell Endocrinol; 2008 May; 286(1-2):135-40. PubMed ID: 17850953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of immune tolerance by anti-inflammatory neuropeptides.
    Gonzalez-Rey E; Chorny A; Delgado M
    Nat Rev Immunol; 2007 Jan; 7(1):52-63. PubMed ID: 17186031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generating tolerogenic dendritic cells with neuropeptides.
    Delgado M
    Hum Immunol; 2009 May; 70(5):300-7. PubMed ID: 19405171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging roles of vasoactive intestinal peptide: a new approach for autoimmune therapy.
    Gonzalez-Rey E; Anderson P; Delgado M
    Ann Rheum Dis; 2007 Nov; 66 Suppl 3(Suppl 3):iii70-6. PubMed ID: 17934101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptides as therapeutic approach to autoimmune diseases.
    Gonzalez-Rey E; Delgado-Maroto V; Souza Moreira L; Delgado M
    Curr Pharm Des; 2010; 16(28):3158-72. PubMed ID: 20687881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasoactive intestinal peptide regulates Th17 function in autoimmune inflammation.
    Leceta J; Gomariz RP; Martinez C; Carrión M; Arranz A; Juarranz Y
    Neuroimmunomodulation; 2007; 14(3-4):134-8. PubMed ID: 18073504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory neuropeptide receptors: new therapeutic targets for immune disorders?
    Gonzalez-Rey E; Delgado M
    Trends Pharmacol Sci; 2007 Sep; 28(9):482-91. PubMed ID: 17688953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptides: keeping the balance between pathogen immunity and immune tolerance.
    Gonzalez-Rey E; Ganea D; Delgado M
    Curr Opin Pharmacol; 2010 Aug; 10(4):473-81. PubMed ID: 20399708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuning immune tolerance with vasoactive intestinal peptide: a new therapeutic approach for immune disorders.
    Pozo D; Gonzalez-Rey E; Chorny A; Anderson P; Varela N; Delgado M
    Peptides; 2007 Sep; 28(9):1833-46. PubMed ID: 17521775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of T-regulatory cells in multiple sclerosis].
    Rojas JI; González SJ; Patrucco L; Cristiano E
    Medicina (B Aires); 2010; 70(1):79-86. PubMed ID: 20228030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-35, a hallmark of immune-regulation in cancer progression, chronic infections and inflammatory diseases.
    Teymouri M; Pirro M; Fallarino F; Gargaro M; Sahebkar A
    Int J Cancer; 2018 Nov; 143(9):2105-2115. PubMed ID: 29574719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diversity of regulatory T cells to control arthritis.
    van Roon JA; Bijlsma JW; Lafeber FP
    Best Pract Res Clin Rheumatol; 2006 Oct; 20(5):897-913. PubMed ID: 16980213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cell tolerogenicity: a key mechanism in immunomodulation by vitamin D receptor agonists.
    Adorini L; Penna G
    Hum Immunol; 2009 May; 70(5):345-52. PubMed ID: 19405173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of regulatory T Cells in autoimmune orchitis.
    Jacobo P
    Andrologia; 2018 Dec; 50(11):e13092. PubMed ID: 30569653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.